Government officials from Tajikistan will learn the Indian experience in harm reduction

24 May 2017

From May 27 to June 2, 2017, delegation of officials from Tajikistan will visit India with a study tour. The aim of the tour is to learn the experience of the implementation of harm reduction programs within the framework of government programs and policies, as well as public financing of harm reduction programs and financial mechanisms non-profit organizations for the implementation of non-medical services within the framework of such programs.

The delegation will include Makhmadrakhim Malakhov, Director of Republican clinical center of narcology named after M.G.Gulyamov, Ministry of Health and Social Protection of Population of the Republic of Tajikistan; Dilshod Saiburkhonov, Deputy Director of Republican AIDS Center, Ministry of Health and Social Protection of Population of the Republic of Tajikistan; Khurshed Bakhromov, key specialist of National center of drug addiction monitoring and prevention, Ministry of Health and Social Protection of Population of the Republic of Tajikistan; Bobokhon Abdurakhimov, Deputy Head of Health Department of Dushanbe, Capital of the Republic of Tajikistan; Pulod Jamolov, Director of NGO “SPIN PLUS”. The delegation will be accompanied by Natalya Podogova and Olga Belyaeva from EHRN Secretariat office.

HIV/AIDS Alliance in India, as a receiving partу provided Eurasian Harm Reduction Network with a comprehensive support. During the visit, the delegation will hold meetings with officials and experts from National AIDS Control Organization, HIV/AIDS Alliance in India, Government run OST site in Tarn Taran civil hospital, All India Institute Of Medical Science (AIIMS) methadone centre, Injecting Drug Users Targeted Intervention (IDU TI) site, UNAIDS and UNODC, and will meet with representatives of NGOs and communities of injecting drug users.

This study tour is organized under the regional program “Harm Reduction Works—Fund It!” implemented with support from the Global Fund to Fight AIDS, Tuberculosis and Malaria.